US2019218245A1PendingUtilityA1
Compounds and methods involving sterols
Est. expiryDec 9, 2034(~8.4 yrs left)· nominal 20-yr term from priority
C07J 51/00C07J 9/00C07J 7/002C07J 17/00
74
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds and methods of synthesizing oxysterols are provided. The compounds and methods provided allow the oxysterol to be safely produced at a high yield. The compounds and methods provided can produce the oxysterol in a stereoselective manner.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A method of making a sterol, the method comprising reacting an organometallic compound with pregnenolone or pregnenolone acetate to form the sterol, the sterol having the formula:
or a pharmaceutically acceptable salt, hydrate or solvate thereof, wherein R 1 comprises an aliphatic or cyclic substituent having at least one carbon atom.
11 . A method of claim 10 , wherein R 1 comprises a (C 1 -C 20 ) alkyl or heteroalkyl, a (C 2 -C 20 ) aryl or heteroaryl, a (C 6 -C 26 ) arylalkyl or heteroalkyl and a (C 5 -C 20 ) arylalkyl or heteroaryl-heteroalkyl, a (C 4 -C 10 ) alkyldiyl or heteroalkyldiyl, or a (C 4 -C 10 ) alkyleno or heteroalkyleno.
12 . A method of claim 10 , wherein the sterol comprises (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(S)-2-hydroxyoctan-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol and the hydrate is a monohydrate.
13 . A method of claim 10 , wherein (i) the organometallic compound comprises the formula R 2 MgX, where X is a halide and R 2 comprises an aliphatic or cyclic substituent having at least one carbon atom or (ii) the organometallic compound comprises the formula R 2 Li, where R 2 comprises an aliphatic or cyclic substituent having at least one carbon atom.
14 . A method of claim 10 , wherein (i) pregnenolone acetate is reacted with the organometallic compound and quenched with aqueous ammonium chloride to produce the sterol in the form of a gel, or (ii) pregnenolone is reacted with the organometallic compound and quenched with acetic acid to produce the sterol in the form of a gel.
15 . A method of claim 14 , wherein pregnenolone is reacted with the organometallic compound at a temperature of less than 5° C.
16 . A method of claim 14 , wherein the sterol is reacted with acetic acid in tetrahydrofuran at a temperature of less than 10° C.
17 . A method of making an oxysterol, the method comprising reacting a diol having the formula:
with borane and hydrogen peroxide to form the oxysterol or a pharmaceutically acceptable salt, hydrate or solvate thereof having the formula:
wherein R 1 comprises an aliphatic or cyclic substituent having at least one carbon atom, and R 2 comprises an aliphatic or cyclic substituent having at least one carbon atom.
18 . A method of claim 17 wherein R 1 and R 2 comprise a hexyl group and the diol comprises (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(S)-2-hydroxyoctan-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol and the hydrate is a monohydrate.
19 . A method of claim 17 wherein (i) the oxysterol is hydrated, (ii) the borane is reacted with the diol at a temperature of less than 5° C., (iii) the hydrogen peroxide is reacted with the diol at a temperature of less than 15° C., (iv) the oxysterol is solidified and separated by filtration, or (v) the oxysterol comprises (3S,5S,6S,8R,9S,10R,13S,14S,17S) 17-((S)-2-hydroxyoctan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol.
20 . A method of claim 17 wherein the reaction is carried out in a single container to yield the oxysterol having the formula
or a pharmaceutically acceptable salt, hydrate or solvate thereof.
21 . A method of making an oxysterol, the method comprising reacting a diol having the formula:
with borane, hydrogen peroxide and tetrahydrofuran to form the oxysterol or a pharmaceutically acceptable salt, hydrate or solvate thereof having the formula:
wherein R 1 is a straight chain alkyl, and R 2 is a straight chain alkyl.
22 . A method of claim 21 wherein R 1 and R 2 comprise a hexyl group and the diol is (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(S)-2-hydroxyoctan-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.
23 . A method of claim 21 wherein (i) the oxysterol is hydrated, (ii) the borane is reacted with the diol at a temperature of less than 5° C., (iii) the oxysterol is solidified and separated by filtration, or (iv) the oxysterol is (3S,5S,6S,8R,9S,10R,13S,14S,17S) 17-((S)-2-hydroxyoctan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,6-diol.
24 . A method of claim 21 wherein the reaction is carried out in a single container to yield the oxysterol having the formula
or a pharmaceutically acceptable salt, hydrate or solvate thereof.
25 . A method of claim 24 , wherein the reaction is carried out in a reaction vessel that is cooled to less than 10° C.
26 . A method of claim 24 , wherein the reaction is carried out in a reaction vessel that is cooled to less than 5° C.
27 . A method of claim 24 , wherein the reaction is carried out in a reaction vessel that is cooled to −5° C.
28 . A method of claim 24 , wherein the hydrogen peroxide is reacted with the diol at a temperature of less than 15° C.Join the waitlist — get patent alerts
Track US2019218245A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.